Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Conditions:   Metastatic Breast Cancer;   Advanced Breast Cancer;   Quality of Life;   Toxicity;   Older Patients Interventions:   Drug: CDK 4/6 inhibitors;   Drug: Endocrine therapy Sponsors:   Region Örebro County;   University of Patras;   University of Florence;   Azienda USL Toscana Centro;   Helsinki University Central Hospital;   Institute for Medical Technology Assessment - the Netherlands;   Security Labs Consulting Limited;   Circular Economy Foundatio n;   Universidad Nacional de Educación a Distancia;   Hellenic Cooperative Oncology Group;   University Hospital, Akershus;   Uppsala County Council, Sweden;   Hospital Clinic of Barcelona;   Phaze Clinical Research & Pharma Consulting;   Bröstcancerförbundet;   Eunomia Ltd;   University of Applied Sciences and Arts Northwestern Switzerland;   CareAcross Ltd;   Örebro University, Sweden Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials